VANCOUVER and SAN DIEGO, Sept. 15 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI - News; OTC: MGIFF - News), a clinical-stage developer of drugs for infectious and degenerative diseases, reports financial results for the three months ended July 31, 2006 and an update on its programs:
